about
Mapping of phospholipids by MALDI imaging (MALDI-MSI): realities and expectationsMaternal Malnutrition in the Etiopathogenesis of Psychiatric Diseases: Role of Polyunsaturated Fatty AcidsDHA supplementation: current implications in pregnancy and childhoodThe role of long chain fatty acids and their epoxide metabolites in nociceptive signalingDocosahexaenoic acid (DHA): an ancient nutrient for the modern human brainLocalized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasoundUsing neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease.Role of cytosolic phospholipase A2 in oxidative and inflammatory signaling pathways in different cell types in the central nervous systemCyclooxygenases and 5-lipoxygenase in Alzheimer's disease.Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.Maternal α-linolenic acid availability during gestation and lactation alters the postnatal hippocampal development in the mouse offspringOmega-3 polyunsaturated Fatty acids and heart rate variability.PPARδ signaling mediates the cytotoxicity of DHA in H9c2 cells.Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo.Chromatin-modifying agents for epigenetic reprogramming and endogenous neural stem cell-mediated repair in stroke.Perturbations in blood phosphatidylcholine and sphingomyelin Fatty Acid composition in a sample population of cigarette smokersInvolvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion.Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation.Lipidomics of Alzheimer's disease: current status.Dietary omega-3 PUFA and health: stearidonic acid-containing seed oils as effective and sustainable alternatives to traditional marine oils.Lipidomics applications in health, disease and nutrition research.Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders.Supplementation of omega 3 fatty acids improves oxidative stress in activated BV2 microglial cell line.Implications of Epigenetic Mechanisms and their Targets in Cerebral Ischemia Models.Docosahexaenoic acid up-regulates both PI3K/AKT-dependent FABP7-PPARγ interaction and MKP3 that enhance GFAP in developing rat brain astrocytes.Effect of acute administration of Pistacia lentiscus L. essential oil on rat cerebral cortex following transient bilateral common carotid artery occlusion.Comparative analysis of gonadal steroid-mediated neuroprotection after transient focal ischemia in rats: route of application and substrate composition.A Novel Combination of Docosahexaenoic Acid, All-Trans Retinoic Acid, and 1, 25-Dihydroxyvitamin D3 Reduces T-Bet Gene Expression, Serum Interferon Gamma, and Clinical Scores but Promotes PPARγ Gene Expression in Experimental Autoimmune EncephalomyeAcute administration of beta-caryophyllene prevents endocannabinoid system activation during transient common carotid artery occlusion and reperfusion.Preventive Effects of Resveratrol on Endocannabinoid System and Synaptic Protein Modifications in Rat Cerebral Cortex Challenged by Bilateral Common Carotid Artery Occlusion and Reperfusion.Combination treatment of docosahexaenoic acid (DHA) and all-trans-retinoic acid (ATRA) inhibit IL-17 and RORγt gene expression in PBMCs of patients with relapsing-remitting multiple sclerosis.Maternal high-fat diet influences outcomes after neonatal hypoxic-ischemic brain injury in rodents.Long-chain omega-3 fatty acids in aneurysmal subarachnoid hemorrhage: A randomized pilot trial of pharmaconutrition.Docosahexaenoic acid supports feto-placental growth and protects cardiovascular and cognitive function: A mini reviewAntiperoxidative properties of oil mixes of high ratio Omega-9:Omega-6 and low ratio Omega-6:Omega-3 after molar extraction in rats
P2860
Q23917133-23F2699A-3808-424A-996E-662DE5E6EDAAQ26740518-94CA74AC-E507-4520-8482-09B5D85FB9B6Q27006939-B1AF6E96-EF55-4C9A-B90C-771B7D01F3EFQ28248377-AD911422-E90D-4F6E-BB78-01DD41553FF7Q28732836-4BEFB844-92F1-4AD5-838E-2D32A8078BC7Q30362081-468C72CE-AE0F-4BCE-ADB1-5746125A7D88Q30451918-8393EE6F-722A-4ED2-B534-CF9836151ECBQ34099708-B740CDFF-724B-43F6-9527-493CE4A242CCQ34551101-B5978CB4-4495-4CA1-8A58-626ED69EF225Q34679377-89D26D48-42BD-4699-BABF-6E77172F127FQ35073930-4D046DB7-9C63-46A2-A49F-650E10B32B96Q35552894-9F68B71B-530E-4A0B-992C-AE520AFF58C5Q35802150-A152507C-B3DE-410B-82A4-CE4838112FBBQ36306413-F6EB820F-ED33-4025-9692-A2AED8F1C735Q37151715-F6D4C8AD-2AA3-4D41-BD26-8EAB1480A265Q37199397-A8B9B47E-FBF3-4A3A-84A0-BDB5F816BBF2Q37595794-EDBE82FC-928D-4D44-8AFA-726265114C64Q37909028-3868683F-FE82-4003-8C1C-691CF1BAC71FQ37980283-E9ACFCCF-A08A-401E-BEFA-E830D99B21E6Q38082480-50ED8647-30E7-402E-ABE2-7870D2F1041EQ38111301-F63649A8-BB3C-4676-A847-D20FFFAAA489Q38629703-C815B96E-4E3C-4171-BCD5-9EA444FE2EC7Q38920687-718AEC15-3B4C-4BC6-AFFD-754EF04E694EQ39037754-A019805B-C0FB-4263-9C7F-078E13226A8CQ39243854-E36902E5-C2FD-4548-9299-6F66CFBDFCDDQ41868953-D3D682ED-A4F8-4B18-B594-91C124750A52Q44494114-908B9FFE-8CC8-474C-A150-76E66B5A60EAQ47999020-316CD929-076B-40B4-B941-0381E1F86D50Q48103877-80223A9A-16FA-42F9-9391-53364263C02CQ48133937-5F41A0EA-B966-4088-AFC3-EFF3BFB980A2Q48271530-1CC96879-E4AA-479F-BE24-C67C5D38147FQ49034754-9F66BA97-63BC-4AF4-B754-0AACE610444BQ49209945-83588979-61CA-4BCE-A9D7-A7653FE3D7F6Q56030877-26820C18-11B3-44A6-858B-5F05181900FFQ57450689-973DFC8A-A3AB-471C-BC80-3AF1820D65E4
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Docosahexaenoic acid neurolipidomics.
@ast
Docosahexaenoic acid neurolipidomics.
@en
Docosahexaenoic acid neurolipidomics.
@nl
type
label
Docosahexaenoic acid neurolipidomics.
@ast
Docosahexaenoic acid neurolipidomics.
@en
Docosahexaenoic acid neurolipidomics.
@nl
prefLabel
Docosahexaenoic acid neurolipidomics.
@ast
Docosahexaenoic acid neurolipidomics.
@en
Docosahexaenoic acid neurolipidomics.
@nl
P2860
P1476
Docosahexaenoic acid neurolipidomics.
@en
P2093
Nicolas G Bazan
Tiffany D Niemoller
P2860
P356
10.1016/J.PROSTAGLANDINS.2009.09.005
P577
2009-10-03T00:00:00Z